News Heater
  • Home
  • Stock Ideas
    • Morning Brief
    • Analyst Insight
    • Equity Research
  • About Newsheater
    • Authors
    • Contact Us
  • Privacy Policy
No Result
View All Result
  • Home
  • Stock Ideas
    • Morning Brief
    • Analyst Insight
    • Equity Research
  • About Newsheater
    • Authors
    • Contact Us
  • Privacy Policy
News Heater
No Result
View All Result
Home Trending

What Sangamo Therapeutics, Inc. (SGMO) Doesn’t Want You to Know

by Nicola Day
September 1, 2020
in Trending
0
Share on FacebookShare on Twitter

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) went up by 1.71% from its latest closing price when compared to the 1-year high value of $13.20 and move down -19.67%, while SGMO stocks collected -1.56% of loss with the last five trading sessions. Barron's reported on 08/20/20 that BioMarin Stock’s Near-Term Growth Is Gone, Analyst Says

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Worth an Investment?

Sangamo Therapeutics, Inc. (NASDAQ: SGMO) The 36 Months beta value for SGMO stocks is at 2.16, while 6 of the analysts out of 9 who provided ratings for Sangamo Therapeutics, Inc. stocks as a “buy” while 0 as overweight, 3 rated it as hold and 0 as sell. The average price we get from analysts is $20.14 which is -$11.03 below current price. SGMO currently has a short float of 16.66% and public float of 116.11M with average trading volume of 2.04M shares.

Related articles

Here’s Our Rant About Cellectar Biosciences Inc. (CLRB)

January 19, 2021

DICK’S Sporting Goods Inc. (DKS) Just Got Our Attention

January 19, 2021

SGMO Market Performance

SGMO stocks went down by -1.56% for the week, with the monthly jump of 1.89% and a quarterly performance of -6.48%, while its annual performance rate touched 1.24%. The simple moving average for the period of the last 20 days is -4.85% for SGMO stocks with the simple moving average of 20.89% for the last 200 days.

Analysts’ Opinion on Sangamo Therapeutics, Inc. (NASDAQ:SGMO)

Many brokerage firms have already submitted their reports for SGMO stocks, with SunTrust repeating the rating for SGMO shares by setting it to “Buy”. The predicted price for SGMO socks in the upcoming period according to SunTrust is $22 based on the research report published on July 7, 2020.

H.C. Wainwright, on the other hand, stated in their research note that they expect to see SGMO stock at the price of $16. The rating they have provided for SGMO stocks is “Buy” according to the report published on August 26, 2019.

JP Morgan gave “ Neutral” rating to SGMO stocks, setting the target price at $16 in the report published on November 14, 2018.

SGMO Stocks 2.37% Far from 50 Day Moving Average

After a stumble in the market that brought SGMO to its low price for the period of the last 52 weeks, Sangamo Therapeutics, Inc. was unable to take a rebound, for now settling with -16.40% of loss for the given period.

The stock volatility was left at 5.42%, however, within the period of a single month, the volatility rate increased by 3.56%, while the shares sank at the distance of -4.38% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by +25.11% upper at the present time.

In the course of the last 5 trading sessions, SGMO went down by -1.56%, which changed the moving average for the period of 200 days to the total of +13.88% of gains for the stock in comparison to the 20-day moving average settled at $11.57. In addition, Sangamo Therapeutics, Inc. saw 31.84% in overturn over the period of a single year with a tendency to cut further gains.

SGMO Stock Insider Trading

Reports are indicating that there were more than several insider trading activities at Sangamo Therapeutics, Inc. (SGMO), starting from DILLY STEPHEN GEORGE, who sold 35,000 shares at the price of $6.00 back on Mar 19. After this action, Rushing now owns 5,000 shares of Sangamo Therapeutics, Inc., valued at $210,000 with the latest closing price.

PARKER H STEWART, the Director of Sangamo Therapeutics, Inc., bought 3,000 shares at the value of $5.20 during a trade that took place back on Mar 18, which means that PARKER H STEWART is holding 13,000 shares at the value of $15,585 based on the most recent closing price.

SGMO Stock Fundamentals

The current profitability levels are settled at -102.69 for the present operating margin. The net margin for Sangamo Therapeutics, Inc. stands at -92.93. Total capital return value is set at -24.12, while invested capital returns managed to touch -21.93. Equity return holds the value -23.10%, with -14.70% for asset returns.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Based on Sangamo Therapeutics, Inc. (SGMO), the company’s capital structure generated 10.27 points for debt to equity in total, while total debt to capital is set at the value of 9.31.

The value for Enterprise to Sales is 6.06 with debt to enterprise value settled at 0.07. The receivables turnover for Sangamo Therapeutics, Inc. is 4.80 with the total asset turnover at the value of 0.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.80.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Tags: IncNASDAQ:SGMOSangamo TherapeuticsSGMOSGMO stock
Share76Tweet48

Related Posts

Here’s Our Rant About Cellectar Biosciences Inc. (CLRB)

by Ethane Eddington
January 19, 2021
0

Cellectar Biosciences Inc. (NASDAQ:CLRB) went down by -1.46% from its latest closing price compared to the recent 1-year high of...

DICK’S Sporting Goods Inc. (DKS) Just Got Our Attention

by Denise Gardner
January 19, 2021
0

DICK'S Sporting Goods Inc. (NYSE:DKS) went down by -1.12% from its latest closing price compared to the recent 1-year high...

Load More
  • Trending
  • Comments
  • Latest

Business Model Helped NIO Stock Add 11 Times To Its Value This Year

November 13, 2020

XL Fleet Corp. (XL) upgraded Issued by Wall Street Gurus

January 12, 2021

Why Enbridge Inc. (ENB)’s Most Recent Report Reveals Some Hints About Its Future

January 13, 2021

Why Applied DNA Sciences Inc. (APDN)’s Most Recent Report Reveals Some Hints About Its Future

January 11, 2021

4 Stocks to Watch Today…

0

A $2 5G Picks and Shovels Company with Bullish Momentum…

0

These 4 Stocks are ready to move!

0

4 Stocks to Watch on Tuesday…

0

Here’s Our Rant About Cellectar Biosciences Inc. (CLRB)

January 19, 2021

Here’s How Your Trade Sandstorm Gold Ltd. (SAND) Aggressively Right Now

January 19, 2021

Is a Correction Looming Ahead for Alphabet Inc. (GOOGL)

January 19, 2021

Riding the Trend or Protecting Profits | Aquestive Therapeutics Inc. (AQST)

January 19, 2021

News Heater

News Heater is specialized on the investments in tech sphere. Its specialists are interested in stocks that have been undervalued by different reasons. They are trying to find them, count their potential and bring them to their clients.

Categories

  • Analyst Insight
  • Business
  • Companies
  • Equity Research
  • Hot Stocks
  • Morning Brief
  • Stock Ideas
  • Trending
  • Uncategorized

Tags

AT&T Inc. Boston Scientific Corporation BSX BSX stock BYND BYND stock Carnival Corporation & Plc Discovery Inc. Exxon Mobil Corporation F FCX Ford Motor Company Fox Corporation F stock Inc JPM JPMorgan Chase & Co. JPM stock KDP KDP stock Keurig Dr Pepper Inc. Moderna Inc. MRNA stock NASDAQ:BYND NASDAQ:QCOM NYSE:BSX NYSE:F NYSE:JPM NYSE:T NYSE:WFC NYSE:XOM PFE stock QCOM QCOM stock QUALCOMM Incorporated T T stock UBER Under Armour Inc. WFC WFC stock WTI XOM XOM stock Zillow Group Inc.

Newsletter

Coming Soon

  • Home
  • About Newsheater
  • Privacy Policy
  • Contact Us

© 2021 Newsheater

No Result
View All Result
  • Homepages
  • Business

© 2020 Newsheater.com

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

236632
236633
236634